2016
 

1.Kiattibutr K, Roobsoong W, Sriwichai P, Saeseu T, Rachaphaew N, Suansomjit C, Buates S, Obadia T, Mueller  I, Cui L, Nguitragool W, Sattabongkot J. Infectivity of symptomatic and asymptomatic Plasmodium vivax infections to a Southeast Asian vector, Anopheles dirus. International journal for parasitology. 2016.
 

2. Koepfli C, Nguitragool W, Hofmann NE, Robinson LJ, Ome-Kaius M, Sattabongkot J, et al. Sensitive and accurate quantification of human malaria parasites using droplet digital PCR (ddPCR). Scientific reports. 2016;6:39183.
 

3. Griffin P, Pasay C, Elliott S, Sekuloski S, Sikulu M, Hugo L, Khoury  D,  Cromer D, Davenport M, Sattabongkot J.

et al. Safety and Reproducibility of a Clinical Trial System Using Induced Blood Stage Plasmodium vivax Infection and Its Potential as a Model to Evaluate Malaria Transmission. PLoS neglected tropical diseases. 2016;10(12):e0005139.
 

4.Li P, Zhao Z, Xing H, Li W, Zhu X, Cao Y, Li W, Yan G, Sattabongkot J, et al. Plasmodium malariae and Plasmodium ovale infections in the China-Myanmar border area. Malaria journal. 2016;15(1):557.
 

5.Longley RJ, Sripoorote P, Chobson P, Saeseu T, Sukasem C, Phuanukoonnon S,  Nguitragool W, Mueller I, Sattabongkot J. High Efficacy of Primaquine Treatment for Plasmodium vivax in Western Thailand. The American journal of tropical medicine and hygiene. 2016;95(5):1086-9.
 

6. Gupta B, Parker DM, Fan Q, Reddy BP, Yan G, Sattabongkot J, et al. Microgeographically diverse Plasmodium vivax populations at the Thai-Myanmar border. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases. 2016;45:341-6.
 

7.Cheng Y, Lu F, Wang B, Li J, Han JH, Ito D, Kong  D. H, Jiang L, Wu J, Ha K S, Takashima E, Sattabongkot, J, et al. Plasmodium vivax GPI-anchored micronemal antigen (PvGAMA) binds human erythrocytes independent of Duffy antigen status. Scientific reports. 2016;6:35581.
 

8.MacDonald NJ, Nguyen V, Shimp R, Reiter K, Herrera R, Burkhardt M, Muratova O, Kumar K, Aebig J, Rausch K, Lambert L, Dawson  N, Sattabongkot  J, et al. Structural and Immunological Characterization of Recombinant 6-Cysteine Domains of the Plasmodium falciparum Sexual Stage Protein Pfs230. The Journal of biological chemistry. 2016;291(38):19913-22.
 

9. Zollner G, Sattabongkot J, Vaughan JA, Kankaew P, Robert LL, Thimasarn K, et al. LONGITUDINAL EVALUATION OF MALARIA EPIDEMIOLOGY IN AN ISOLATED VILLAGE IN WESTERN THAILAND: I. STUDY SITE AND ADULT ANOPHELINE BIONOMICS. The Southeast Asian journal of tropical medicine and public health. 2016;47(3):341-65.
 

10.Baum E, Sattabongkot J, Sirichaisinthop J, Kiattibutr K, Jain A, Taghavian O, et al. Common asymptomatic and submicroscopic malaria infections in Western Thailand revealed in longitudinal molecular and serological studies: a challenge to malaria elimination. Malaria journal. 2016;15:333.
 

12. Menard D, Khim N, Beghain J, Adegnika AA, Shafiul-Alam M, Amodu O, et al. A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms. The New England journal of medicine. 2016;374(25):2453-64.
 

13. Patrapuvich R, Lerdpanyangam K, Jenwithisuk R, Rungin S, Boonhok R, Duangmanee A, Yimamnuaychok, N.

Sattabongkot  J. VIABILITY AND INFECTIVITY OF CRYOPRESERVED PLASMODIUM VIVAX SPOROZOITES. The Southeast Asian journal of tropical medicine and public health. 2016;47(2):171-81.
 

14.Han JH, Lee SK, Wang B, Muh F, Nyunt MH, Na S, Ha, K. S, Park, W. S, Sattabongkot  J, et al. Identification of a reticulocyte-specific binding domain of Plasmodium vivax reticulocyte-binding protein 1 that is homologous to the PfRh4 erythrocyte-binding domain. Scientific reports. 2016;6:26993.
 

15. Wongkidakarn S, McHenry AM, Sattabongkot J, Adams JH, Chootong P. Strain-Transcending Inhibitory Antibodies against Homologous and Heterologous Strains of Duffy Binding Protein region II. PloS one. 2016;11(5):e0154577.
 

16.Bennett JW, Yadava A, Tosh D, Sattabongkot J, Komisar J, Ware LA, et al. Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy. PLoS neglected tropical diseases. 2016;10(2):e0004423.
 

17. Longley RJ, Sattabongkot J, Mueller I. Insights into the naturally acquired immune response to Plasmodium vivax malaria. Parasitology. 2016;143(2):154-70.
 

18.Sriwichai P, Samung Y, Sumruayphol S, Kiattibutr K, Kumpitak C, Payakkapol A, Kaewkungwal J, Yan G,

Cui L,Sattabongkot J. Natural human Plasmodium infections in major Anopheles mosquitoes in western Thailand. Parasites & vectors. 2016;9:17.
 

19. Hupalo DN, Luo Z, Melnikov A, Sutton PL, Rogov P, Escalante A, et al. Population genomics studies identify signatures of global dispersal and drug resistance in Plasmodium vivax. Nature genetics. 2016;48(8):953-8.
 

20. Gruszczyk J, Lim NT, Arnott A, He WQ, Nguitragool W, Roobsoong W, et al. Structurally conserved erythrocyte-binding domain in Plasmodium provides a versatile scaffold for alternate receptor engagement. 2016;113(2):E191-200.
 

21. Boonhok R, Rachaphaew N, Duangmanee A, Chobson P, Pattaradilokrat S, Utaisincharoen P, Sattabongkot J et al. LAP-like process as an immune mechanism downstream of IFN-gamma in control of the human malaria Plasmodium vivax liver stage. 2016;113(25):E3519-28.
 

22. Prachumsri JS. Focus, Prioritize, Collaborate. Trends in parasitology. 2016;32(9):659-60.